What's in Arbutus Biopharma Corporation's pipeline?

Arbutus Biopharma Corporation has 2 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with Arbutus Biopharma Corporation's portfolio?

Top competitors by shared drug class: Ain Shams University, Australasian Gastro-Intestinal Trials Group, Casa Sollievo della Sofferenza IRCCS, Hospital Universitari Vall d'Hebron Research Institute, Invivyd, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/arbutus-biopharma-corporation.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Arbutus Biopharma Corporation — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Arbutus Biopharma Corporation pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Infectious Diseases · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams University · 1 shared drug class
Australasian Gastro-Intestinal Trials Group · 1 shared drug class
Casa Sollievo della Sofferenza IRCCS · 1 shared drug class
Hospital Universitari Vall d'Hebron Research Institute · 1 shared drug class
Invivyd, Inc. · 1 shared drug class
JW Pharmaceutical · 1 shared drug class
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 1 shared drug class
Pfizer · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Arbutus Biopharma Corporation:

Cite this brief

Drug Landscape (2026). Arbutus Biopharma Corporation — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/arbutus-biopharma-corporation. Accessed 2026-05-18.